Novo Fined For Delaying News Of FDA's Blocking Of Drug
Health care company Novo Nordisk A/S has been slapped with a fine from Danish regulators for not informing investors soon enough that two insulin drugs it had hoped would drive growth...To view the full article, register now.
Already a subscriber? Click here to view full article